IFCT

The Intergroupe Francophone de Cancérologie Thoracique (IFCT) is a premier French academic research organization dedicated to improving the survival and quality of life for patients with thoracic cancers. Founded in 1999, the IFCT coordinates a vast network of clinicians and researchers to design and execute independent clinical trials, ranging from early-phase studies to large-scale Phase 3 trials. The organization focuses on innovative therapies, including immunotherapies and targeted agents, for indications such as non-small cell lung cancer and mesothelioma. By integrating clinical research with translational science, the IFCT plays a critical role in establishing new standards of care in thoracic oncology.